114 related articles for article (PubMed ID: 1967979)
1. Mechanisms of multidrug resistance in HL60 cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein.
Marquardt D; McCrone S; Center MS
Cancer Res; 1990 Mar; 50(5):1426-30. PubMed ID: 1967979
[TBL] [Abstract][Full Text] [Related]
2. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein.
Krishnamachary N; Center MS
Cancer Res; 1993 Aug; 53(16):3658-61. PubMed ID: 8101765
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug.
McGrath T; Center MS
Cancer Res; 1988 Jul; 48(14):3959-63. PubMed ID: 2898287
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of multidrug resistance in HL60 cells. Analysis of resistance associated membrane proteins and levels of mdr gene expression.
McGrath T; Latoud C; Arnold ST; Safa AR; Felsted RL; Center MS
Biochem Pharmacol; 1989 Oct; 38(20):3611-9. PubMed ID: 2573357
[TBL] [Abstract][Full Text] [Related]
5. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein.
Jedlitschky G; Leier I; Buchholz U; Center M; Keppler D
Cancer Res; 1994 Sep; 54(18):4833-6. PubMed ID: 7915193
[TBL] [Abstract][Full Text] [Related]
6. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
Politi PM; Sinha BK
Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
[TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of membrane protein changes in multidrug resistant HL-60 cells.
Krishnamachary N; Center MS
Oncol Res; 1992; 4(1):23-8. PubMed ID: 1581617
[TBL] [Abstract][Full Text] [Related]
8. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells.
Meyers MB; Rittmann-Grauer L; O'Brien JP; Safa AR
Cancer Res; 1989 Jun; 49(12):3209-14. PubMed ID: 2566379
[TBL] [Abstract][Full Text] [Related]
9. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A.
Gollapudi S; Gupta S
Anticancer Res; 1992; 12(6B):2127-32. PubMed ID: 1363515
[TBL] [Abstract][Full Text] [Related]
10. Adriamycin resistance in HL60 cells and accompanying modification of a surface membrane protein contained in drug-sensitive cells.
Marsh W; Center MS
Cancer Res; 1987 Oct; 47(19):5080-6. PubMed ID: 3621192
[TBL] [Abstract][Full Text] [Related]
11. Identification of a P-glycoprotein-related protein (mini-P-glycoprotein) which is overexpressed in multidrug resistant cells.
Kawai K; Kusano I; Ido M; Sakurai M; Shiraishi T; Yatani R
Biochem Biophys Res Commun; 1994 Jan; 198(2):804-10. PubMed ID: 7905266
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies.
Flens MJ; Izquierdo MA; Scheffer GL; Fritz JM; Meijer CJ; Scheper RJ; Zaman GJ
Cancer Res; 1994 Sep; 54(17):4557-63. PubMed ID: 7914828
[TBL] [Abstract][Full Text] [Related]
13. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
[TBL] [Abstract][Full Text] [Related]
14. Analysis of MRP gene expression and function in HL60 cells isolated for resistance to adriamycin.
Krishnamachary N; Ma L; Zheng L; Safa AR; Center MS
Oncol Res; 1994; 6(3):119-27. PubMed ID: 7994083
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
[TBL] [Abstract][Full Text] [Related]
16. Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells.
Marquardt D; Center MS
Cancer Res; 1992 Jun; 52(11):3157-63. PubMed ID: 1591727
[TBL] [Abstract][Full Text] [Related]
17. Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.
Yusa K; Tsuruo T
Cancer Res; 1989 Sep; 49(18):5002-6. PubMed ID: 2569930
[TBL] [Abstract][Full Text] [Related]
18. Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance.
Gerlach JH; Endicott JA; Juranka PF; Henderson G; Sarangi F; Deuchars KL; Ling V
Nature; 1986 Dec 4-10; 324(6096):485-9. PubMed ID: 2878368
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
Politi PM; Arnold ST; Felsted RL; Sinha BK
Mol Pharmacol; 1990 Jun; 37(6):790-6. PubMed ID: 1972771
[TBL] [Abstract][Full Text] [Related]
20. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells.
Hamada H; Okochi E; Watanabe M; Oh-hara T; Sugimoto Y; Kawabata H; Tsuruo T
Cancer Res; 1988 Dec; 48(24 Pt 1):7082-7. PubMed ID: 2903793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
